Internal Medicine, Hematology & Oncology · Port St Lucie, FL
NPI
1861448243
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1871 SE Tiffany Ave, Suite 100
Port St Lucie, FL, 34952
Phone (772) 335-5666
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.3M
190,133 services
Medicare patients, 2024
1,016
Average age 76
Drug cost, 2024
$4.1M
1,442 prescriptions
Company payments, 2025
$285
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul M Swanson was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 24,480 times for 28 patients. In total Paul M Swanson billed 190,133 services in 167 codes, and Medicare paid $3.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 24,480 | 28 | $0.26 | $6,449 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 22,800 | 26 | $44.56 | $1.0M |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 22,620 | 20 | $0.38 | $8,689 |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 21,180 | 17 | $0.22 | $4,599 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 4,390 | 19 | $5.77 | $25K |
| J0897 Injection, denosumab, 1 mg | Office | 4,140 | 20 | $20.63 | $85K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 3,828 | 16 | $21.05 | $81K |
| 85025 Blood Count | Office | 2,236 | 660 | $7.58 | $17K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,941 | 47 | $0.09 | $175 |
| 36415 Venipuncture Blood Collection | Office | 1,655 | 586 | $8.63 | $14K |
| 99213 Office E&M - Established | Office | 1,568 | 476 | $67.79 | $106K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,500 | 11 | $0.10 | $152 |
| 80053 Clinical Chemistry | Office | 1,427 | 505 | $10.34 | $15K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 919 | 44 | $0.23 | $207 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 845 | 40 | $0.70 | $588 |
By year: 2022 $4.1M for 263,095 services; 2023 $4.3M for 250,113 services; 2024 $3.3M for 190,133 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,236 | 660 | $7.58 | $17K |
| 36415 Venipuncture Blood Collection | 1,655 | 586 | $8.63 | $14K |
| 80053 Clinical Chemistry | 1,427 | 505 | $10.34 | $15K |
| 83615 Clinical Chemistry | 353 | 145 | $5.90 | $2,084 |
| 82728 Clinical Chemistry | 272 | 126 | $13.31 | $3,621 |
| 83540 Clinical Chemistry | 226 | 116 | $6.31 | $1,427 |
| 83550 Clinical Chemistry | 224 | 115 | $8.53 | $1,911 |
| 84153 Clinical Chemistry | 133 | 45 | $18.02 | $2,397 |
| 82378 Clinical Chemistry | 124 | 76 | $18.58 | $2,304 |
| 86300 Immunoassay | 71 | 44 | $20.39 | $1,448 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul M Swanson prescribed most often to Medicare patients was Eliquis (Apixaban), with 91 prescriptions and refills. In total Paul M Swanson wrote 1,442 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 91 | 121 | 17 | $69K |
| Hydroxyurea Generic | 88 | 183 | 23 | $2,131 |
| Anastrozole Generic | 76 | 200 | 21 | $920 |
| Xtandi Enzalutamide | 59 | 59 | 11 | $828K |
| Ondansetron Hcl Generic | 56 | 57 | 23 | $295 |
| Prednisone Generic | 50 | 78 | 22 | $545 |
| Imbruvica Ibrutinib | 44 | 44 | Under 11 | $390K |
| Abiraterone Acetate Generic | 44 | 44 | Under 11 | $47K |
| Alprazolam Generic | 43 | 43 | 12 | $362 |
| Lorazepam Generic | 39 | 39 | 18 | $203 |
| Lenalidomide Generic | 39 | 39 | Under 11 | $464K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 37 | 37 | 12 | $1,333 |
| Lupron Depot Leuprolide Acetate | 34 | 128 | 14 | $263K |
| Dexamethasone Generic | 33 | 36 | 11 | $529 |
| Oxycodone Hcl Generic | 33 | 33 | 22 | $347 |
Brand drugs: - claims; generic drugs: 1,018 claims; opioid claims: 140.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul M Swanson $285 ($285 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $96.48.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.